Susan Wathen requested Harvoni treatment from her hospital following a discussion with a professor at the Hepatitis C Trust patient conference. Her hospital subsequently applied to the clinical commissioning group for funding. However this was denied as she was not considered "ill enough" for treatment. She was eventually treated with Harvoni after a two-year delay between diagnosis and receiving treatment.